Vidéo
Visionnage de 4 min
13 mars 2025
LA SANTÉ COMMUNAUTAIRE ET MONDIALE
prod:prod_dcx-login
Le besoin
- Measurement of blood plasma HIV-1 RNA using PCR is established as the standard of care in assessing HIV-positive patient prognosis and response to antiretroviral therapy
- It is estimated that only 75% of people living with HIV worldwide have access to viral load testing. In Low and Middle-Income Countries (LMICs), this figure is below 50%1
- HIV viral load tests that can be deployed beyond centralized laboratories are needed to expand access to the standard of care1
1 Malisa et al 2023 Nature Scientifc Reports | (2023) 13:4578 | https://doi.org/10.1038/s41598-023-31103-y
La solution
- The Xpert HIV-1 Viral Load XC test is an on-demand quantitative PCR test incorporating dual target detection for extended strain coverage
- Using GeneXpert® technology, the Xpert HIV-1 Viral Load XC test automates the test process in one fully integrated cartridge and enables testing in laboratory or near‑patient testing environments
- Provides users with advantages of simple workflow, fast results, and flexibility for low-to-high volume testing
Xpert® HIV‑1 Viral Load XC is intended to be performed by trained professional users or trained healthcare workers in laboratory or near-patient testing environments.
L’impact
- Support streamlined care pathways with fast sample collection and result availability
